Immunotherapy resistance in melanoma

ABSTRACT: Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 and/or Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets

PROVIDER: PRJEB45846 | ENA |

REPOSITORIES: ENA